FDA medical device approvals get external review

Sep 23, 2009 By MATTHEW PERRONE , AP Business Writer

(AP) -- The Food and Drug Administration is asking the government's top medical advisers to review its system for approving certain types of medical devices, which has been criticized by safety advocates and government watchdogs.

The nonprofit Institute of Medicine will conduct a two-year review of FDA's so-called 510k review procedure, which allows device companies to quickly launch products similar to those already on the market.

The announcement Wednesday garnered approval from lawmakers on Capitol Hill who have been skeptical of the FDA program.

"I have long been concerned that the 510k process permits too many devices on the market about whose safety and effectiveness even the FDA is uncertain," said Rep. Henry Waxman. "The result is hundreds of recalls of important devices for serious safety concerns."

The California Democrat chairs the House Energy and Commerce Committee, which oversees the FDA.

The procedure was originally intended to speed the approval of simple devices like bandages and wheelchairs, but in recent years it has been used to approve high-risk devices.

The Government Accountability Office, Congress' investigative arm, recently identified two-dozen device types that were approved without close scrutiny, including hip replacements and heart implants.

Normally, companies have to submit the results of large patient studies before launching such devices. But by arguing that their devices are similar to other FDA-approved products, companies can speed up the approval process. Under the 510k system, manufacturers simply have to give the FDA 90 days notice of their intent to launch their product.

The FDA said in a statement that medical technology has changed quickly in recent decades "making it an appropriate time ... to review the adequacy of the pre-market notification program."

The Institute of Medicine's review is expected to cost $1.3 million and its findings will be published in March 2011, according to the FDA.

The Advanced Medical Technology Association, which represents device makers like Medtronic Inc. and Boston Scientific Corp., called the 510k process a "well-defined, science-driven method." The trade group urged the institute to seek input from industry experts.

The institute, which advises the federal government on medical issues, is expected to hold two workshops in coming months to gather comments from industry, physicians and patients.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Booming mobile health app market needs more FDA oversight for consumer safety, confidence

add to favorites email to friend print save as pdf

Related Stories

FDA approves cervical disk device

Jul 17, 2007

The U.S. Food and Drug Administration Tuesday announced approval of the first device designed to treat cervical degenerative disc disease.

FDA requires faster food safety reporting

Sep 08, 2009

(AP) -- Food makers will be required to alert government officials of potentially contaminated products within 24 hours under a new rule designed to help federal regulators spot food safety issues sooner.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments : 0